![]() |
市场调查报告书
商品编码
1859793
全球生物肥料和生物农药市场:预测至2032年-按产品类型、形态、应用方法、作物类型和地区分類的分析Biofertilizers & Biopesticides Market Forecasts to 2032 - Global Analysis By Product Type, Form, Mode of Application, Crop Type, and By Geography |
||||||
根据 Stratistics MRC 的数据,全球生物肥料和生物农药市场预计到 2025 年将达到 92 亿美元,到 2032 年将达到 189 亿美元,预测期内复合年增长率为 10.9%。
生物肥料和生物农药利用有益微生物、昆虫病原体和植物萃取物来改善养分循环、抑制病原体并提升土壤健康,是合成化学物质的替代方案。这些农药支持可再生农业,减少食品中的残留,同时也能发挥生态系服务功能。永续性政策、消费者需求以及提高稳定性和延长保质期的配方创新推动了市场成长。
根据美国农业部(USDA)的数据,2017 年至 2022 年,美国作物生产中生物肥料和生物农药的使用量增加了 12%。
对有机食品的需求日益增长
消费者对有机和无残留食品的需求不断增长,是生物肥料和生物农药市场发展的关键驱动力。为了满足监管标准和消费者对永续性、减少化学残留和更清洁标籤的期望,农民和食品品牌正在采用微生物投入品。这种消费者偏好推动了田间试验的增加、采购预算的增加,以及农业投入品公司和生技开发商之间合作的加强。此外,有机农产品的溢价和出口机会改善了农场的经济效益,使生物基投入品具有商业性吸引力,并刺激了对配方和分销的投资。
缩短储存期
许多微生物肥料保质期短、产品稳定性差,导致储存、运输和库存管理复杂,限制了市场扩张。活性微生物在高温、干燥或长期储存条件下会失去活性,降低田间肥效,削弱农民信心。这增加了物流成本,提高了对低温运输和防腐剂的需求,并限制了分销,尤其是在炎热或偏远地区。此外,配方劣化导致的田间肥效不稳定也会减缓推广应用,并增加监管审查,因此,改进配方科学和包装对于扩大商业应用规模至关重要。
发现更强大、更有效的微生物菌株
发现并商业化更稳健、用途更广的微生物菌株,为该产业带来了巨大的成长机会。菌株筛检、微生物群落设计和製剂科学的进步,能够培育出具有更高抗逆性、更强活力和更适合作物生长的微生物。兼具营养物质活化和病原体抑制功能的新型菌株,能够提供组合式价值提案减少农民对化学投入品的依赖。增加研发投入、进行田间示范和完善监管途径,将加速产品推广,从而实现差异化产品、更强的功效宣称,并促进不同种植系统中农民的快速采用。
来自大型化学企业的激烈竞争
来自现有化肥和农药企业的激烈竞争对纯粹的生物肥料供应商构成重大威胁。这些企业拥有庞大的分销网络、雄厚的研发预算以及与农民的牢固关係,使其能够捆绑产品、制定极具竞争力的价格,并迅速推出自有品牌产品。此外,熟悉的监管环境和值得信赖的品牌也进一步加剧了消费者对现有企业的偏好。为了捍卫市场份额,生物技术公司必须透过田间试验、可靠的数据和密集的农民培训来展现其明显的农艺优势,同时还要建立经销伙伴,并抵消化肥和农药生产商的规模经济优势。
疫情扰乱了供应链和农田作业,导致生物肥料生产商在短期内生产和分销受阻。旅行限制和劳动力短缺延缓了田间试验,并限制了原材料采购,而农民则优先考虑提高短期产量的投入品。然而,人们对粮食安全和韧性的日益重视重新燃起了对生物解决方案的兴趣。疫情后的復苏推动了对更具韧性的供应链和数位化推广服务的投资,从而促进了需求的恢復和生物基农业投入品的长期应用。
预计在预测期内,液体燃料部分将是最大的组成部分。
预计在预测期内,液体製剂将占据最大的市场份额,因为液体製剂更易于施用,可与灌溉和叶面喷布系统相容,并能提供更均匀的微生物分布。农民偏好液体製剂,因为它们能快速被田间吸收,易于整合到灌溉系统中,且便于罐混。载体技术和防腐剂的改进缓解了过去的稳定性问题,使其更加可靠。大型商业农场和精准施肥系统更倾向于精确的液体製剂剂量,因此液体製剂的采用率很高,并巩固了其在液体製剂领域的市场主导地位。
预计种子处理领域在预测期内将实现最高的复合年增长率。
预计在预测期内,种子处理行业将呈现最高的成长率,因为种子处理能够以最小的额外劳动力投入,提供早期高效的保护和促进生长。播种时施用微生物可将微生物直接输送到种子与根系的界面,从而提高微生物的定殖率和养分吸收,因此深受连续种植者和园艺种植者的青睐。载体和包衣技术的进步提高了微生物在储存和播种过程中的存活率。此外,种子处理与病虫害综合治理和机械化播种相结合,与其他施用方法相比,推动了其快速普及和相对较高的成长。
在预测期内,北美预计将占据最大的市场份额,这得益于其先进的农业基础设施、完善的分销管道以及对永续农业的强有力的製度支持。大型商业农场、高农民收入以及充满活力的研发生态系统加速了产品的测试和推广应用。政策奖励、有机耕地溢价以及领先生物肥料生产商的存在进一步提高了产品的可及性和市场信心。这些因素共同创造了成熟的商业环境,从而推动了生物基投入品的广泛应用,并使其占据了主导的市场份额。
预计亚太地区在预测期内将实现最高的复合年增长率,耕地面积扩大、粮食需求增长、农村交通便利化程度提高以及政府支持力度加大,都推动了相关技术的快速普及。本地新兴企业和全球公司正在推出低成本、在地化的配方产品,而推广服务和私部门培训则促进了农民的采纳。亚太地区是成长最快的区域市场,这得益于其庞大的潜在人口和日益增长的机械化水平,从而能够实现快速规模化发展。
According to Stratistics MRC, the Global Biofertilizers & Biopesticides Market is accounted for $9.2 billion in 2025 and is expected to reach $18.9 billion by 2032, growing at a CAGR of 10.9% during the forecast period. Biofertilizers and biopesticides leverage beneficial microbes, entomopathogens, and botanical extracts to improve nutrient cycling, suppress pathogens, and enhance soil health as alternatives to synthetic chemicals. They support regenerative agriculture and reduced residue in food while enabling ecosystem services. Market growth is enabled by sustainability policies, consumer demand, and formulation innovations that increase stability and shelf life.
According to the United States Department of Agriculture (USDA), the use of biofertilizers and biopesticides in U.S. crop production increased by 12% between 2017 and 2022.
Rising demand for organic food
Rising consumer demand for organic and residue-free food is a primary driver for the biofertilizers and biopesticides market. Farmers and food brands increasingly adopt microbial inputs to meet regulatory standards and consumer expectations for sustainability, reduced chemical residues, and cleaner labels. This buyer preference raises field trials, procurement budgets, and collaborations between agri-input firms and biotech developers. Moreover, price premiums and export opportunities for organic produce improve farmer economics, making bio-based inputs commercially attractive and accelerating investment into formulation and distribution.
Shorter shelf life
Shorter shelf life and product stability for many microbial biofertilizers constrain market expansion by complicating storage, transport, and inventory management. Live microbes can lose viability under heat, desiccation, or prolonged storage, reducing field efficacy and farmer confidence. This raises logistics costs, increases cold-chain or preservative needs, and limits distribution reach especially in hot or remote regions. Moreover, variability in on-farm performance linked to degraded formulations slows adoption and invites greater regulatory scrutiny, making formulation science and improved packaging essential to scale commercial use.
Discovery of more robust and effective microbial strains
Discovery and commercialization of more robust, multi-functional microbial strains offer a substantial growth opportunity for the sector. Advances in strain screening, microbial consortia design, and formulation science can deliver microbes with improved stress tolerance, survival, and broader crop compatibility. Novel strains that combine nutrient mobilisation with pathogen suppression enable bundled value propositions that reduce farmers' dependence on chemical inputs. Increased R&D funding, field demonstrations, and regulatory pathways can accelerate product rollouts, enabling differentiated offerings, stronger efficacy claims, and faster farmer adoption across cropping systems.
Strong Competition from Chemical Giants
Strong competition from established chemical fertilizer and agrochemical companies represents a material threat to specialist biofertilizer vendors. Incumbents hold deep distribution networks, large R&D budgets, and strong farmer relationships; they can bundle offerings, employ aggressive pricing, and rapidly launch bio-branded lines. Regulatory familiarity and trusted brands further tilt buyer preference toward incumbents. To defend market share, biotech firms must demonstrate clear agronomic benefits through local trials, robust data, and intensive farmer training while building distribution partnerships that neutralise the scale advantages of chemical players.
The pandemic disrupted supply chains and field operations, creating short-term production and distribution setbacks for biofertilizer manufacturers. Travel restrictions and labour shortages delayed field trials and constrained raw-material sourcing, while farmers prioritised immediate yield inputs. However, increased attention to food security and resilience spurred renewed interest in biological solutions. Post-pandemic recovery saw investment in more resilient supply chains and digital extension services, supporting recovery of demand and longer-term adoption of bio-based agricultural inputs.
The liquid segment is expected to be the largest during the forecast period
The liquid segment is expected to account for the largest market share during the forecast period because liquid products offer simpler application, compatibility with fertigation and foliar systems, and more uniform microbial distribution. Farmers favour liquids for rapid field uptake, integration into irrigation, and ease of tank mixing, which reduces labour and application complexity. Improvements in carrier technologies and preservatives have mitigated past stability issues, increasing confidence. Large commercial farms and precision systems prefer liquid dosing for accuracy, which supports higher adoption and solidifies the liquid segment's dominant market position.
The seed treatment segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the seed treatment segment is predicted to witness the highest growth rate because seed applications deliver early, efficient protection and growth promotion with minimal added labour. Applying microbes at sowing places them directly at the seed-root interface, improving establishment and nutrient uptake advantages valued by both row-crop and horticultural producers. Advances in carriers and pelleting technologies have improved microbial survival during storage and planting. Moreover, seed treatment integrates well with integrated pest management and mechanised sowing, driving faster adoption and higher relative growth than other application methods.
During the forecast period, the North America region is expected to hold the largest market share driven by advanced agricultural infrastructure, well-developed distribution channels, and strong institutional support for sustainable farming. Large commercial farms, high farm incomes, and active R&D ecosystems accelerate product testing and uptake. Policy incentives, organic acreage premiums, and presence of major biofertilizer manufacturers further improve availability and trust. Together these factors create a mature commercial environment where bio-based inputs achieve broad adoption and capture a leading share of the market.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR because expanding arable area, rising food demand, improving rural connectivity, and stronger government support drive rapid adoption. Local startups and global firms are launching low-cost, locally adapted formulations while extension services and private sector training boost farmer acceptance. High addressable populations and increasing mechanisation make the region fertile for rapid scale-up, positioning Asia Pacific as the fastest-growing regional market.
Key players in the market
Some of the key players in Biofertilizers & Biopesticides Market include Bayer AG, BASF SE, Syngenta AG, Corteva Agriscience, FMC Corporation, UPL Limited, Marrone Bio Innovations, Inc., Valent BioSciences LLC, Certis USA LLC, Novozymes A/S, Koppert Biological Systems B.V., Andermatt Biocontrol AG, BioWorks, Inc., Lallemand Inc., Bioceres Crop Solutions Corp., and Rizobacter Argentina S.A.
In October 2025, Bayer CropScience launched the world's first bioinsecticide for arable crops, highlighting its commitment to sustainable farming and increased biological insecticide adoption. Bayer is focusing research and production in Germany on strategic technologies to maintain competitiveness amid significant industry challenges. It has also filed for regulatory approvals for new herbicide molecules in major markets while continuing legal strategies related to glyphosate liabilities.
In June 2025, Syngenta AG announced it is significantly expanding its research & development capabilities in agricultural biologicals, including acquiring assets (natural compounds and genetic strains) from Novartis AG for agricultural biological use.
In April 2024, Bayer AG signed an agreement with AlphaBio Control securing exclusive rights to market a new biological insecticide for arable crops (oilseed rape and cereals), targeting pests such as the cabbage stem flea beetle.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.